MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations

MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations is a paper indexed in ScholarIQ from OpenAlex.

How many citations does MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations have?

MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations has 5 citations in the OpenAlex counts ScholarIQ stores.

When was MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations published?

MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations has 2025 year in the ScholarIQ index.

What is the open-access status of MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations?

MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations has hybrid oa status in the ScholarIQ index.

What is the DOI of MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations?

The DOI for MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations is on the source record.

What is the PMID of MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations?

The PMID for MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations is on the source record.

What is the OpenAlex record for MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations?

The OpenAlex for MEK inhibitors are effective in Erdheim–Chester disease regardless of MAPK pathway mutations is on the source record.